Curcumin solid lipid particles and methods for their preparation and use
Solid lipid particles comprising a lipid hydrophobic matrix and from about 5 wt. % to about 30 wt. % of curcumin, and methods of making and treatment thereof.
1. Solid lipid particles comprising: a lipid hydrophobic matrix; and from about 5 wt. % to about 30 wt. % of curcumin, wherein said lipid hydrophobic matrix comprises
5 wt. % to 30 wt. % lecithin;
5 wt. % to 15 wt. % glycerol behenate; and
at least 40 wt. % mixture of monoglycerides, diglycerides, and triglycerides having a carbon number ranging from C6 to C40, and wherein said solid lipid particles have an average particle size diameter ranging from 100 μm to 1500 μm.
2. The solid lipid particles according to claim 1 , wherein the lipid hydrophobic matrix has a melting point ranging from about 15° C. to about 85° C.
3. The solid lipid particles according to claim 1 , wherein the lipid hydrophobic matrix has a melting point ranging from about 30° C. to about 45° C.
4. The solid lipid particles according to claim 1 , wherein the curcumin has an average particle size diameter ranging from about 0.1 μm to about 10 μm.
5. The solid lipid particles according to claim 1 , wherein the solid lipid particles have a substantially spherical shape.
6. A solid lipid particle according to claim 1 , wherein the lipid hydrophobic mixture comprises
about 5 wt. % to about 15 wt. % curcumin
about 5 wt. % lecithin;
and at least 50 wt. % mixture of monoglycerides, diglycerides, and triglycerides having a carbon number ranging from C 6 to C 40 .
7. The solid lipid particle of claim 1 comprising
about 15 wt. % curcumin
about 15 wt. % lecithin;
about 5 wt. % glycerol behenate; and
about 65 wt. % mixture of monoglycerides, diglycerides, and triglycerides having a carbon number ranging from C 6 to C 40 .
8. The solid lipid particle of claim 1 comprising
15 wt. % curcumin
20 wt. % propylene glycol monocaprylate,
10 wt. % propylene glycol dicaprylate/dicaprate,
5 wt. % glycerol behenate, and
50 wt. % a mixture of monoglycerides, diglycerides, and triglycerides having a carbon number ranging from C 6 to C 40 .
9. The solid lipid particle of claim 7 comprising:
15 wt. % curcumin wherein the curcumin has an average particle size diameter from about 0.1 μm to about 10 μm;
20 wt. % propylene glycol caprylate;
10 wt. % propylene glycol dicaprylate/dicaprate;
5 wt. % glycerol behenate, and
50 wt. % a mixture of monoglycerides, diglycerides, and triglycerides having a carbon number ranging from C 6 to C 40 .
10. A solid lipid particle according to claim 1 , wherein the curcumin is comprised in an amount of from 5% wt to 15% wt and wherein said solid lipid particle comprises:
5% wt to 30% wt propylene glycol monocaprylate,
5% wt to 30% wt propylene glycol dicaprylate/dicaprate,
5% wt to 15% wt glycerol behenate,
and at least 40% wt a mixture of monoglycerides, diglicerides, and triglicerides having a carbon number ranging from C6 to C40.
11. A pharmaceutical composition comprising one or more solid lipid particles according to claim 1 .
12. A process for preparing solid lipid particles according to claim 1 , wherein the process comprises:
dispersing a lipid phase having a melting point ranging from about 15° C. to about 85° C. in a gel phase at a temperature above the melting point of the lipid phase to form a dispersion;
cooling the dispersion to obtain solid lipid particles;
separating the solid lipid particles; and
optionally, washing the solid lipid particles;
wherein the solid lipid particles comprise a lipid hydrophobic matrix; and from about 5 wt. % to about 30 wt. % of curcumin.
13. The process according to claim 12 , wherein the solid lipid particle further comprise surfactant.